Search results
PROMOTED
Author(s):
Nicolas M Van Mieghem
,
Kendra J Grubb
,
David Hildick-Smith
,
et al
Start date:
Mar 26, 2024
Yuhui Zhang
Author
James C Moon
Research Area(s) / Expertise:
Job title: Clinical Director of Imaging
Author
Author(s):
Matt Thompson
Added:
3 years ago
Since its inception in the early 1990s, endovascular repair (EVR) of aneurysms has been subjected to analysis in several randomised controlled trials. Now it is a mainstay of treatment for abdominal aortic aneurysms (AAA). As the technique has moved from conception through competitive analysis and finally into mainstream practice, several issues have remained controversial. These will be…
View more
Author(s):
Anna Caggegi
,
Davide Capodanno
,
Claudia Tamburino
,
et al
Added:
3 years ago
Identifying the most appropriate revascularisation strategy for patients affected by unprotected left main coronary artery (ULMCA) disease has been considered a topic of great interest and discussion in the past few years. Although coronary artery bypass grafting (CABG) is still conventionally regarded as the standard of care for patients with significant ULMCA disease eligible for surgery,…
View more
Author(s):
Rhys Gray
,
Kiran Sarathy
Added:
2 years ago
AI in Cardiac Imaging and IC
Author(s):
Karthik Seetharam
,
Sirish Shrestha
,
Partho P Sengupta
Added:
2 years ago
Article
Author(s):
Paul Sorajja
Added:
11 months ago
EuroPCR 23 - Dr Paul Sorajja (Abbott Northwestern Hospital, US) joined us to discuss the TRILUMINATE Pivotal study (NCT03904147).
The aim of this trial is to evaluate the safety and effectiveness of the tricuspid transcatheter edge-to-edge repair (TriClip, Abbott) in improving clinical outcomes for symptomatic patients with severe tricuspid regurgitation (TR) who have an intermediate or higher…
View more
Author(s):
Frederik Zimmermann
Added:
2 years ago
In this late-breaking interview from ACC.22, Dr Frederik Zimmermann (Catharina Hospital, NL) outlines the main findings of the FAME 3 Trial.
FAME 3 is an international, randomised multicentre trial, that aims to compare the outcomes of fractional flow reserve (FFR)-guided PCI and Coronary Artery Bypass Graft Surgery (CABG) in patients with multivessel coronary artery disease. The results…
View more
Marc Evans
Author